Più Medical reports 31% revenue growth in first half of 2026

Più Medical reported a 31% increase in pro-forma consolidated revenues for the first half of 2026, reaching 17.5 million euros compared to 13.4 million euros in the same period the previous year. The company's pro-forma net result rose to 603,000 euros, up from 100,000 euros in the first half of 2025.

While adjusted EBITDA for pharmacies grew by 16% to 2.5 million euros, the group's consolidated adjusted EBITDA decreased from 2 million to 1.8 million euros. This margin contraction, from 14.8% to 10.4%, was attributed to investments in integration for recent acquisitions and the strengthening of the central structure. The results include the impact of Farmacia Formaggia, which was formally acquired on July 2.